A new framework for advancing in drug‐induced liver injury research. The Prospective European <scp>DILI</scp> Registry

Abstract

In this first multi-national European prospective DILI Registry study, antibacterials were the most commonly implicated medications, whereas antineoplastic and immunomodulating agents accounted for higher proportion of DILI than previously described. This European initiative provides an important opportunity to advance the study on DILI.